THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 1 filers reported holding THERAVANCE INC in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $22,000 | +214.3% | 2,126 | +127.9% | 0.00% | – |
| Q3 2015 | $7,000 | 0.0% | 933 | +132.1% | 0.00% | – |
| Q2 2015 | $7,000 | +16.7% | 402 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | -99.5% | 402 | -99.0% | 0.00% | -100.0% |
| Q2 2014 | $1,191,000 | -3.8% | 40,000 | 0.0% | 0.04% | -7.9% |
| Q1 2014 | $1,238,000 | -6.1% | 40,000 | +8.1% | 0.04% | -11.6% |
| Q4 2013 | $1,319,000 | -52.6% | 37,000 | -45.6% | 0.04% | -55.2% |
| Q3 2013 | $2,781,000 | +106.2% | 68,000 | +94.3% | 0.10% | +104.3% |
| Q2 2013 | $1,349,000 | +3.8% | 35,000 | -36.4% | 0.05% | +2.2% |
| Q1 2013 | $1,299,000 | +45.8% | 55,000 | +37.5% | 0.05% | +31.4% |
| Q4 2012 | $891,000 | -50.9% | 40,000 | -42.9% | 0.04% | -52.1% |
| Q3 2012 | $1,814,000 | -4.0% | 70,000 | -17.6% | 0.07% | -14.1% |
| Q2 2012 | $1,889,000 | +7.6% | 85,000 | -5.6% | 0.08% | +7.6% |
| Q1 2012 | $1,755,000 | +98.5% | 90,000 | +125.0% | 0.08% | +97.5% |
| Q4 2011 | $884,000 | – | 40,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
| Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
| SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
| Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
| Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
| Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
| BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
| PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |